Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
AIDS Research and Human Retroviruses|December 31, 2021
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral RegimenLaura Magnasco, Rachele Pincino, Giuseppe Pasculli, et al.
Viruses|May 27, 2023
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected PatientsMassimiliano Fabbiani, Melissa Masini, Barbara Rossetti, et al.
International Journal of Antimicrobial Agents|July 12, 2022
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIVGiulia Stella, Lorenzo Volpicelli, Domenico Di Carlo, et al.
Antiviral Therapy|March 3, 2020
Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCADavide Fiore Bavaro, Domenico Di Carlo, Barbara Rossetti, et al.
Antiviral Therapy|April 14, 2025
Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA databaseLaura Labate, Barbara Rossetti, Chiara Russo, et al.
The Journal of Antimicrobial Chemotherapy|February 24, 2026
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomesLaura Pezzati, Federico Conti, William Gennari, et al.
Antiviral Research|July 9, 2019
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort studyBarbara Rossetti, Gianmaria Baldin, Gaetana Sterrantino, et al.
Journal of Medical Virology|March 31, 2022
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort studyDavide F Bavaro, Andrea De Vito, Giuseppe Pasculli, et al.
HIV Medicine|July 28, 2021
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohortMassimiliano Fabbiani, Barbara Rossetti, Arturo Ciccullo, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus InfectionBarbara Rossetti, Valentina Borgo, Arianna Emiliozzi, et al.
Pageof 7